EF
FBIO icon

Empowered Funds’s Fortress Biotech FBIO Stock Holding History

Empowered Funds’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.5K Buy
+25,000
New +$64.5K ﹤0.01% 2091

Other funds holding FBIO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Empowered Funds's FBIO Position: Q2 2026 in Review

Empowered Funds opened a new position in Fortress Biotech (FBIO) in Q2 2026: 25,000 shares worth $76.5K. The stake represents ﹤0.01% of the portfolio and ranks #2091 among its holdings.

55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Empowered Funds held 25,000 shares of Fortress Biotech worth $76.5K as of Q2 2026.
  • Fortress Biotech was a new Empowered Funds position in Q2 2026.
  • Fortress Biotech made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #2091 holding.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.